Interpretable ADC-based radiomics models for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Key Points
The ADC-based model robustly differentiates hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC), showcasing its effectiveness.
Validated with public data, the model demonstrates strong generalizability across heterogeneous cases to be clinically useful.
Assessment using ADC-based radiomics reveals high accuracy in differentiation with significant implications for patient diagnosis.
These findings suggest that adopting this non-invasive tool may enhance diagnostic clarity in liver cancer types like HCC and ICC.
Abstract
The ADC-based LR model robustly differentiates HCC from ICC, with validated generalizability using public data, offering a promising non-invasive clinical tool.